SIGLEC5
SIGLEC5 (sialic acid-binding Ig-like lectin 5, also known as CD170, OB-BP2, SIGLEC-5 and CD33L2) is a membrane lectin of the immunoglobulin superfamily. It is a putative adhesion molecule that mediates sialic acid-dependent binding to cells. Browse Assay Genie's current range of SIGLEC5 research reagents below, or read on for the biology behind the target.
SIGLEC5 is a putative adhesion molecule that mediates sialic acid-dependent binding to cells. It binds equally to alpha-2,3-linked and alpha-2,6-linked sialic acid. Its sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface, which is a recognised feature of how Siglec lectins can be regulated at the cell surface. The encoded protein inhibits the activation of several cell types, including monocytes, macrophages and neutrophils.
The SIGLEC5 gene encodes a member of the sialic acid-binding immunoglobulin-like lectin (Siglec) family. These cell surface lectins are characterised by structural motifs in their immunoglobulin (Ig)-like domains, with the sialic acid recognition site located in the first Ig V-set domain. SIGLEC5 belongs to the CD33-related subset of Siglecs and sits within the HGNC groups for CD molecules, V-set domain containing proteins and sialic acid binding Ig-like lectins. The mouse ortholog is Siglec5.
Binding of group B Streptococcus (GBS) to the SIGLEC5 protein plays a role in GBS immune evasion, linking this lectin to host-pathogen interactions. The protein is also known as CD170, and earlier aliases include OB-BP2 and CD33L2. Researchers studying the SIGLEC5 gene or protein typically do so in the context of sialic acid recognition, inhibitory signalling in myeloid cells and innate immune responses to bacteria.
SIGLEC5 inhibits the activation of monocytes, macrophages and neutrophils, making it relevant to studies of inhibitory control of innate immune cells.
SIGLEC5 binds alpha-2,3- and alpha-2,6-linked sialic acid equally, and cis interactions may mask its binding site on the same cell.
Binding of group B Streptococcus to SIGLEC5 contributes to GBS immune evasion, which makes it a focus in bacterial pathogenesis research.
As a CD33-related Siglec, SIGLEC5 is studied alongside other family members to compare sialic acid specificity and immune function.
SIGLEC5 is a putative adhesion molecule that mediates sialic acid-dependent binding to cells. It inhibits the activation of several cell types, including monocytes, macrophages and neutrophils. Its sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface.
SIGLEC5 is also called CD170, SIGLEC-5, OB-BP2 and CD33L2. The HGNC full name is sialic acid binding Ig like lectin 5. It is a member of the CD33-related subset of the Siglec family, and it belongs to the immunoglobulin superfamily.
Binding of group B Streptococcus (GBS) to SIGLEC5 plays a role in GBS immune evasion. The mouse ortholog is Siglec5, but check the datasheet of any product for its validated reactivity before use in a given species.
Other Siglec family lectins, including CD33-related members, with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O15389; product specifications from Assay Genie datasheets.